Research Topics
Genomes and GenesSpecies | Deddo MoertlSummaryAffiliation: Medical University of Vienna Country: Austria Publications
| Collaborators
|
Detail Information
Publications
Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of deathDeddo Moertl
Department of Cardiology, Medical University of Vienna, Vienna, Austria
J Am Coll Cardiol 53:1783-90. 2009....- Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm studyDeddo Moertl
Department of Cardiology, Medical University of Vienna, Austria
Am Heart J 161:915.e1-9. 2011..However, a dose-efficacy relationship was postulated for the beneficial effects of n3-PUFA before. Therefore, we evaluated dose-dependent effects of n3-PUFA in patients with severe CHF... - Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patientsDeddo Moertl
Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Eur J Heart Fail 10:404-11. 2008..We evaluated the prognostic value of sequential NT-proBNP values in ambulatory heart failure patients after discharge, investigating whether the current value or the recent percent change is more important... - B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failureDeddo Moertl
Department of Cardiology, Medical University of Vienna, Vienna, Austria
J Card Fail 15:233-40. 2009..However, which patients really benefit from such an intervention remains unclear. We investigated if B-type natriuretic peptide (BNP), a strong prognostic marker in chronic heart failure, can predict benefit from HBNC... - Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failureDeddo Moertl
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Thromb Haemost 106:457-65. 2011..2 was decreased by 4 g/day n3-PUFA (P = 0.03). In patients with severe non-ischaemic CHF, treatment with n3-PUFA leads to a dose-dependent decrease of platelet activation and TF. Higher dosage exhibits also anti-inflammatory effects... - Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the diseaseStephanie Neuhold
Department of Cardiology, Medical University of Vienna, Vienna, Austria
J Am Coll Cardiol 52:266-72. 2008.... 
Levosimendan and prostaglandin E1 for uptitration of beta-blockade in patients with refractory, advanced chronic heart failureRudolf Berger
Department of Cardiology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090, Vienna, Austria
Eur J Heart Fail 9:202-8. 2007..In advanced chronic heart failure (CHF) 20% of patients do not tolerate beta-blockers and 50% do not reach target doses...- N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot studyRudolf Berger
Department of Cardiology, Medical University of Vienna, Vienna, Austria
J Am Coll Cardiol 55:645-53. 2010.... 
Endothelial markers may link kidney function to cardiovascular events in type 2 diabetesChristina Maier
Department of Endocrinology, Medical University Hospital Vienna, Vienna, Austria
Diabetes Care 32:1890-5. 2009..The aim of this study was to investigate the role of stable fragments of the precursors of adrenomedullin, endothelin-1, vasopressin, and atrial natriuretic peptide in progression of cardiovascular disease in patients with diabetes...- NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitusMartin Huelsmann
Department of Cardiology, Medical University Vienna, Vienna, Austria
Eur Heart J 29:2259-64. 2008..This study evaluated the predictive value of NT-proBNP for patients with diabetes mellitus and compared the prognostic aptitude of this neurohumoral marker to traditional markers of cardiovascular events... - Cost analysis and cost-effectiveness of NT-proBNP-guided heart failure specialist care in addition to home-based nurse careChristopher Adlbrecht
Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Eur J Clin Invest 41:315-22. 2011..As re-hospitalization is the main contributing economic factor in heart failure expenditures, we hypothesized that this programme might be able to reduce costs and could be conducted cost effectively compared to UC... - N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patientsBrigitte Meyer
Department of Cardiology, Clinical Institute for Medical and Chemical Laboratory Diagnostics, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria
Crit Care Med 35:2268-73. 2007..The present study tests the prognostic information of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in an unselected cohort of critically ill patients... - Heart transplantation provides long-term survival benefit in stable patients experiencing heart failure without reverse left ventricular remodelingBrigitte Meyer
Department of Cardiology, Medical University of Vienna, Vienna, Austria
Transplantation 82:1463-71. 2006..5 years) but in the long term (7-10 years), heart transplantation seems to provide survival benefit in stable patients with CHF except in patients with improved LVEF (> or =30%) after medical optimization... - Network meta-analysis of prasugrel, ticagrelor, high- and standard-dose clopidogrel in patients scheduled for percutaneous coronary interventionsSabine Steiner
Department of Internal Medicine II, Division of Angiology, Medical University Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
Thromb Haemost 108:318-27. 2012.... - Influence of cytochrome 2C19 allelic variants on on-treatment platelet reactivity evaluated by five different platelet function testsThomas Gremmel
Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
Thromb Res 129:616-22. 2012..Allelic variants of CYP2C19 were determined with the Infiniti® CYP450 2C19+ assay and categorized into four metabolizer states (ultrarapid, extensive, intermediate, poor)... - Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysisGregor Lindner
Department of Medicine III, Division of Nephrology, Vienna, Austria
Wien Klin Wochenschr 121:391-7. 2009..Little, however, is known about prognostic indices and outcome in patients with CHF who (sub-)acutely progress to dialysis dependency... - Short-term effects of levosimendan and prostaglandin E1 on hemodynamic parameters and B-type natriuretic peptide levels in patients with decompensated chronic heart failureDeddo Moertl
Department of Cardiology, Medical University of Vienna, Austria
Eur J Heart Fail 7:1156-63. 2005..Both levosimendan and prostaglandin E1 (PGE1) have beneficial effects on hemodynamic parameters and outcome compared to dobutamine in decompensated chronic heart failure (CHF)...